Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1401326

	registered interest
	date	10/01/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Children: Protection
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the accountable officer for health in multi-agency safeguarding partnerships has the (a) seniority and (b) health expertise required to commit the Integrated Care Board to decisions on policy, resourcing and practice matters following the transfer of statutory responsibility for child safeguarding from Clinical Commissioning Groups to Integrated Care Boards under the proposals in the Health and Care Bill.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	100501
	answer	answer is ministerial correction date of answer 18/01/2022 answer text <p>The statutory guidance ‘Working together to safeguard children’ designates accountable officers or chief nurses of clinical commissioning groups (CCGs) and their counterparts in local authorities and police forces as representatives of the three safeguarding partners in an area. This provides an equal and joint responsibility for local child safeguarding arrangements. All existing child safeguarding responsibilities for CCGs will transfer to the respective integrated care board. The guidance sets out clear expectations on appropriate delegation and this will continue to apply to safeguarding partners for health.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 18/01/2022 16:29:07 answering member 4447 label Biography information for Maggie Throup
	tabling member	4005 label Biography information for Bob Blackman

1401327

	registered interest
	date	10/01/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Integrated Care Boards: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he will take to assess the effectiveness of Integrated Care Boards in delivering the statutory child safeguarding responsibilities transferred to them under the Health and Care Bill's proposals.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	100502
	answer	answer is ministerial correction date of answer 18/01/2022 answer text <p>All existing child safeguarding responsibilities on clinical commissioning groups (CCGs) will transfer to the respective integrated care board, which must continue to have regard to the duties on safeguarding partners set out in the statutory guidance ‘Working together to safeguard children’.</p><p>NHS England has a responsibility to safeguard all users of its services, including children. It assures this responsibility, including the safeguarding duties currently with CCGs, through the NHS Safeguarding Accountability and Assurance Framework. This is supported by the Safeguarding Commissioning Assurance Toolkit, its network of Regional Safeguarding Leads, and the designated and named professionals for safeguarding in every CCG, general practitioner practice and relevant health provider. This will continue to apply.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup question first answered 18/01/2022 16:47:12 answering member 4447 label Biography information for Maggie Throup
	tabling member	4005 label Biography information for Bob Blackman

1401328

	registered interest
	date	10/01/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Children: Protection
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of Health and Care Bill proposals to amalgamate Clinical Commissioning Groups into Integrated Care Boards on the geographical boundaries of multi-agency safeguarding arrangements.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	100503
	answer	answer is ministerial correction date of answer 18/01/2022 answer text <p>Many local child safeguarding partnerships already work across the different geographical footprints of local authorities, clinical commissioning groups (CCGs) and police forces. ‘Working together to safeguard children’ sets out the expectations for how partnerships should work across geographical boundaries, including on appropriate delegation where a senior leader is responsible for more than one partnership. All existing child safeguarding responsibilities for CCGs will transfer to the respective integrated care board, which must continue to have regard to the duties on safeguarding partners in ‘Working together to safeguard children’.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 18/01/2022 16:43:35 answering member 4447 label Biography information for Maggie Throup
	tabling member	4005 label Biography information for Bob Blackman

1402744

	registered interest
	date	13/01/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department takes to ensure that the upper gestational limits on abortion are guided by the latest science on foetal viability; and whether his Department has made an assessment of the implications for its policies of the findings on foetal viability from 22 weeks gestation in (a) Riley K., et al., Survival and neurodevelopmental morbidity at 1 year of age following extremely preterm delivery over a 20-year period: a single centre cohort study, published in Acta Paediatrica in 2008, (b) MBRRACE-UK Supplementary report on survival up to one year of age for babies born before 27 weeks gestational age — For Births in Great Britain from January to December 2016, Maternal, Newborn and Infant Clinical Outcome Review Programme published in 2019 and (c) Håkansson S. et al., Proactive Management Promotes Outcome in Extremely Preterm Infants: A Population-Based Comparison of Two Perinatal Management Strategies, published in Pediatrics in 2004.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	103537
	answer	answer is ministerial correction date of answer 21/01/2022 answer text <p>It would be a matter for Parliament to determine whether changes to the law on abortion should be made. As with other matters of conscience, abortion is an issue on which the Government adopts a neutral stance and allows hon. Members to vote according to their moral, ethical or religious beliefs.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 103538 question first answered 21/01/2022 09:23:53 answering member 4447 label Biography information for Maggie Throup
	tabling member	4005 label Biography information for Bob Blackman

1402745

	registered interest
	date	13/01/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to review the current upper gestational limit on abortion of 24 weeks in response to the latest advancements in perinatal medicine showing fetal viability from 22 weeks, and given that the median time limit in other European countries is 12 weeks gestation.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	103538
	answer	answer is ministerial correction date of answer 21/01/2022 answer text <p>It would be a matter for Parliament to determine whether changes to the law on abortion should be made. As with other matters of conscience, abortion is an issue on which the Government adopts a neutral stance and allows hon. Members to vote according to their moral, ethical or religious beliefs.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 103537 question first answered 21/01/2022 09:23:53 answering member 4447 label Biography information for Maggie Throup
	tabling member	4005 label Biography information for Bob Blackman

1467465

	registered interest
	date	01/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what monitoring and data systems are in place to evaluate the effectiveness of emergency treatments administered to patients vulnerable to covid-19.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	11649
	answer	answer is ministerial correction date of answer 14/06/2022 answer text <p>NHS England and NHS Improvement collect data on treatments for eligible patients hospitalised due to COVID-19, hospital-onset COVID-19 and non-hospitalised patients treated through COVID Medicines Delivery Units. Data is collected on the numbers of treatments prescribed and administered and published weekly at the following link:</p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/covid-therapeutics-antivirals-and-neutralising-monoclonal-antibodies/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/covid-therapeutics-antivirals-and-neutralising-monoclonal-antibodies/</a></p><p>Data is also collected on hospitalisation rates for treated and untreated patients. NHS England and NHS Improvement continue to work with the research community to monitor this observational data and understand the impact of treatments on patient outcomes.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 14/06/2022 16:22:05 answering member 4447 label Biography information for Maggie Throup
	tabling member	4005 label Biography information for Bob Blackman

1467466

	registered interest
	date	01/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the US FDA's withdrawal of authorisation for the use of Sotrovimab for treatment of covid-19 on 5 April 2022, what steps he is taking to ensure the (a) stringency and (b) consistency of his Department's reviews of (i) Evusheld and (ii) other covid-19 treatments.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	11650
	answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>The Antivirals and Therapeutics Taskforce engages with other nations to share learning on the use, deployment and evaluation of COVID-19 therapeutics and antivirals which may inform policy. The UK Health Security Agency is monitoring the effectiveness of all COVID-19 therapeutics, including sotrovimab. The RAPID C-19 collaborative, the National Health Service and other relevant experts provide advice to the United Kingdom Chief Medical Officers on whether treatments should be recommended for deployment, taking account of all available evidence.</p><p>The Department is currently reviewing prophylaxis and the efficacy of Evusheld. The Therapeutics Clinical Review Panel provides advice on the appropriate patient cohorts for potential new COVID-19 therapies, including preventative treatments. Final clinical policies and eligibility would be proposed by the NHS and agreed by the UK Chief Medical Officers.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup question first answered 21/06/2022 10:16:47 answering member 4447 label Biography information for Maggie Throup
	tabling member	4005 label Biography information for Bob Blackman

1467486

	registered interest
	date	01/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answet of 31 May 2022 to Question 6744 on dementia diagnosis, what assessment he has made of the impact the £17 million in funding to clinical commissioning groups on dementia diagnosis rates in England.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	11651
	answer	answer is ministerial correction date of answer 13/06/2022 answer text <p><strong> </strong></p><p>No formal assessment has been made as the full impact of the funding cannot yet be determined. NHS England and NHS Improvement continue to monitor the monthly diagnosis rate and are analysing trends at regional and sustainability and transformation partnership level to aid targeted recovery efforts. Work to improve dementia diagnosis rates will continue in 2022/23. We will set out plans for dementia in England for the next 10 years later this year, including on diagnosis, risk reduction and prevention and research.</p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 13/06/2022 12:14:24 answering member 4680 label Biography information for Gillian Keegan
	tabling member	4005 label Biography information for Bob Blackman

1567591

	registered interest
	date	17/01/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Smoking: Health Education
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much his Department spent on campaigns to promote the cessation of smoking in 2021-22; and how much is budgeted to be spent for that purpose in 2022-23.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	125324
	answer	answer is ministerial correction date of answer 24/01/2023 answer text <p>Expenditure by the Department on smoking cessation promotion for the period 1 October until the end of the financial year 2021/22 was £660,000.</p><p>Budgets for the current financial year are subject to ongoing review to enable the Department to respond to external changes and challenges. The figures reference expenditure for advertising on television, radio, national press, regional press, out of home, social and digital advertising. However, recruitment advertising, paid search and media partnerships are not included. The spend figure for the 2022/23 will be available once costs have been consolidated after the financial year has ended.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 24/01/2023 11:43:14 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4005 label Biography information for Bob Blackman

1567592

	registered interest
	date	17/01/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tobacco
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much the Office for Health Improvement and Disparities spent on tobacco control policy and implementation in 2021-22; and how much is budgeted to be spent by that office for that purpose in 2022-23.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	125325
	answer	answer is ministerial correction date of answer 25/01/2023 answer text <p>In the 2021/22 financial year, the Office for Health Improvement and Disparities spent £901,873 on tobacco control policy and implementation and the 2022/23 budget is up to £1,182,000.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 25/01/2023 11:23:37 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4005 label Biography information for Bob Blackman